Mehmet Durgun1, Emine Kübra Dindar Demiray2, Sevil Alkan Çeviker3

1Department of Chest Diseases and Tuberculosis, Bitlis State Hospital, Bitlis, Turkey
2Department of Infectious Diseases and Clinical Microbiology, Bitlis State Hospital, Bitlis, Turkey
3Department of Infectious Diseases and Clinical Microbiology, Çanakkale Onsekiz Mart University Faculty of Medicine, Çanakkale, Turkey

Keywords: COVID-19, lung, smoking

Abstract

Smoking leads to the development of many respiratory system diseases, including chronic obstructive pulmonary disease and lung cancer. By hindering the protective mechanisms of our non-respiratory tract, it provides convenient conditions for respiratory infections. Smoking is an important risk factor for the infection and spread of COVID-19. Our historical information demonstrates that the use of tobacco products negatively affects patients' chances of survival during MERS-CoV and SARS-CoV, outbreaks of the same family as COVID-19. Considering the harms of smoking, it can be predicted that its exposure negatively affects the course of COVID-19 disease, both directly and indirectly. The aim of this review is to evaluate the relationship between smoking and COVID-19 in the light of current literature.

Conflict of Interest

The authors declared no conflicts of interest with respect to the authorship and/or publication of this article.

Financial Disclosure

The authors received no financial support for the research and/or authorship of this article.